CapsoVision, Inc. (CV) vs Standard BioTools Inc. (LAB)
A side-by-side comparison of CapsoVision, Inc. and Standard BioTools Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.40HealthcareDelayed quote: Oct 6, 2026, 10:22 AM EDT
LAB
Standard BioTools Inc.
$0.78HealthcareDelayed quote: Oct 6, 2026, 10:24 AM EDT
Total return — CV vs LAB
growth of $100 · dividends reinvested · last 1yCV +88.3% (+88.3%/yr)LAB -36.4% (-36.4%/yr)CV compounded faster over this window
CV LAB
CV vs LAB: by the numbers
- •CV is the larger company ($320M vs $306M market cap).
- •Both run net losses; LAB's is the smaller (-103.29% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | CV | LAB |
|---|---|---|
| P/S ratio | 23.02 | 3.61 |
| P/B ratio | 24.29 | 0.57 |
Profitability
| Metric | CV | LAB |
|---|---|---|
| Gross margin | 50.88% | 49.14% |
| Operating margin | -188.25% | -109.34% |
| Net margin | -214.74% | -103.29% |
| ROE | -226.56% | -16.18% |
| ROIC | -164.32% | -14.06% |
Growth (annualized)
| Metric | CV | LAB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.62% |
| Total return CAGR (5Y) | N/A | -32.98% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.